Next Article in Journal
Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
Previous Article in Journal
Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases
Previous Article in Special Issue
Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessFeature PaperArticle
J. Clin. Med. 2017, 6(2), 14; doi:10.3390/jcm6020014

Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders

1
Department of Psychology, The City College of New York, CUNY, 160 Convent Avenue, NAC Building, Rm 7/120, New York, NY 10031, USA
2
Department of Psychology, Pace University, 861 Bedford Road, Pleasantville, NY 10570, USA
3
Gordon F. Derner Institute for Advanced Psychological Studies, Adelphi University, IAPS, Hy Weinberg Center, Room 306, Garden City, NY 11530-0701, USA
4
Division on Substance Use Disorders, Department of Psychiatry, Columbia University Medical Center/New York State Psychiatric Institute, 1051 Riverside Drive, Box 66, New York, NY 10032, USA
5
Sophie Davis School of Biomedical Education, The City College of New York, 160 Convent Avenue, New York, NY 10031, USA
6
Department of Psychiatry, NYU School of Medicine, 1 Park Avenue, New York, NY 10016, USA
7
Department of Psychology and Institute for Mental Health Research, University of Texas, Austin, 108 E. Dean Keeton Street, Austin, TX 78712, USA
8
Gordon F. Derner Institute for Advanced Psychological Studies, Adelphi University & Department of Psychiatry, Columbia University College of Physicians and Surgeons, Hy Weinberg Center, Room 306, Garden City, NY 11530-0701, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Frances Kay Lambkin and Emma Barrett
Received: 18 September 2016 / Revised: 19 January 2017 / Accepted: 22 January 2017 / Published: 7 February 2017
(This article belongs to the Special Issue Post-Traumatic Stress Disorder 2016)
View Full-Text   |   Download PDF [530 KB, uploaded 14 February 2017]   |  

Abstract

Background: Research has demonstrated a strong link between trauma, posttraumatic stress disorder (PTSD) and substance use disorders (SUDs) in general and cannabis use disorders in particular. Yet, few studies have examined the impact of cannabis use on treatment outcomes for individuals with co-occurring PTSD and SUDs. Methods: Participants were 136 individuals who received cognitive-behavioral therapies for co-occurring PTSD and SUD. Multivariate regressions were utilized to examine the associations between baseline cannabis use and end-of-treatment outcomes. Multilevel linear growth models were fit to the data to examine the cross-lagged associations between weekly cannabis use and weekly PTSD symptom severity and primary substance use during treatment. Results: There were no significant positive nor negative associations between baseline cannabis use and end-of-treatment PTSD symptom severity and days of primary substance use. Cross-lagged models revealed that as cannabis use increased, subsequent primary substance use decreased and vice versa. Moreover, results revealed a crossover lagged effect, whereby higher cannabis use was associated with greater PTSD symptom severity early in treatment, but lower weekly PTSD symptom severity later in treatment. Conclusion: Cannabis use was not associated with adverse outcomes in end-of-treatment PTSD and primary substance use, suggesting independent pathways of change. The theoretical and clinical implications of the reciprocal associations between weekly cannabis use and subsequent PTSD and primary substance use symptoms during treatment are discussed. View Full-Text
Keywords: trauma; PTSD; cannabis; substance use disorder; treatment outcomes trauma; PTSD; cannabis; substance use disorder; treatment outcomes
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ruglass, L.M.; Shevorykin, A.; Radoncic, V.; Smith, K.M.Z.; Smith, P.H.; Galatzer-Levy, I.R.; Papini, S.; Hien, D.A. Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders. J. Clin. Med. 2017, 6, 14.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top